BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 11113857)

  • 1. The role of cytochrome P450 in tumour development and progression and its potential in therapy.
    Murray GI
    J Pathol; 2000 Dec; 192(4):419-26. PubMed ID: 11113857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-specific expression of cytochrome P450 CYP1B1.
    Murray GI; Taylor MC; McFadyen MC; McKay JA; Greenlee WF; Burke MD; Melvin WT
    Cancer Res; 1997 Jul; 57(14):3026-31. PubMed ID: 9230218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Profiling cytochrome P450 expression in ovarian cancer: identification of prognostic markers.
    Downie D; McFadyen MC; Rooney PH; Cruickshank ME; Parkin DE; Miller ID; Telfer C; Melvin WT; Murray GI
    Clin Cancer Res; 2005 Oct; 11(20):7369-75. PubMed ID: 16243809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Role of cytochrome P450 enzymes in the metabolism of antineoplastic drugs].
    Quiñones S L; Rosero P M; Roco A A; Moreno T I; Sasso A J; Varela F N; Cáceres L D; Saavedra S I
    Rev Med Chil; 2008 Oct; 136(10):1327-35. PubMed ID: 19194632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytochrome p450 profile of colorectal cancer: identification of markers of prognosis.
    Kumarakulasingham M; Rooney PH; Dundas SR; Telfer C; Melvin WT; Curran S; Murray GI
    Clin Cancer Res; 2005 May; 11(10):3758-65. PubMed ID: 15897573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA expression of cytochrome P450 in breast cancer patients.
    Vaclavikova R; Hubackova M; Stribrna-Sarmanova J; Kodet R; Mrhalova M; Novotny J; Gut I; Soucek P
    Anticancer Res; 2007; 27(6C):4443-50. PubMed ID: 18214058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytochrome P450 pharmacogenetics and cancer.
    Rodriguez-Antona C; Ingelman-Sundberg M
    Oncogene; 2006 Mar; 25(11):1679-91. PubMed ID: 16550168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of cytochrome P450 in tumor tissues and its association with cancer development.
    Oyama T; Kagawa N; Kunugita N; Kitagawa K; Ogawa M; Yamaguchi T; Suzuki R; Kinaga T; Yashima Y; Ozaki S; Isse T; Kim YD; Kim H; Kawamoto T
    Front Biosci; 2004 May; 9():1967-76. PubMed ID: 14977602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytochromes P450 of insects: the tip of the iceberg.
    Scott JG; Wen Z
    Pest Manag Sci; 2001 Oct; 57(10):958-67. PubMed ID: 11695190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytochrome p450 and chemical toxicology.
    Guengerich FP
    Chem Res Toxicol; 2008 Jan; 21(1):70-83. PubMed ID: 18052394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytochrome P450. Mechanisms of action and clinical implications.
    Williams MT
    J Fla Med Assoc; 1992 Jun; 79(6):405-8. PubMed ID: 1640215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Marine invertebrate cytochrome P450: emerging insights from vertebrate and insects analogies.
    Rewitz KF; Styrishave B; Løbner-Olsen A; Andersen O
    Comp Biochem Physiol C Toxicol Pharmacol; 2006 Aug; 143(4):363-81. PubMed ID: 16769251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-induced changes in P450 enzyme expression at the gene expression level: a new dimension to the analysis of drug-drug interactions.
    Lee MD; Ayanoglu E; Gong L
    Xenobiotica; 2006; 36(10-11):1013-80. PubMed ID: 17118918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of polymorphic human cytochrome P450 enzymes in estrone oxidation.
    Cribb AE; Knight MJ; Dryer D; Guernsey J; Hender K; Tesch M; Saleh TM
    Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):551-8. PubMed ID: 16537715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The role of cytochrome P-450 in chemical carcinogenesis--its application to human cancer epidemiology].
    Tagashira Y
    Gan No Rinsho; 1987 Apr; 33(5 Suppl):619-26. PubMed ID: 3599468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of paclitaxel-inactivating CYP3A activity in human colorectal cancer: implications for drug therapy.
    Martínez C; García-Martín E; Pizarro RM; García-Gamito FJ; Agúndez JA
    Br J Cancer; 2002 Sep; 87(6):681-6. PubMed ID: 12237780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of oxazaphosphorines by cytochrome P450: application to gene-directed enzyme prodrug therapy for cancer.
    Roy P; Waxman DJ
    Toxicol In Vitro; 2006 Mar; 20(2):176-86. PubMed ID: 16293390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Combined tumor chemotherapy/gene therapy based on the activation of antineoplastic agents by genetic constructions of cytochromes p450].
    Sokolova NN; Iatsenko AN; Pokrovskaia MV
    Vopr Med Khim; 1999; 45(6):462-71. PubMed ID: 10761211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Environmental contaminants in pathogenesis of breast cancer.
    Mukherjee S; Koner BC; Ray S; Ray A
    Indian J Exp Biol; 2006 Aug; 44(8):597-617. PubMed ID: 16924830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of cytochrome P450 gene expression and arachidonic acid metabolism during isoproterenol-induced cardiac hypertrophy in rats.
    Zordoky BN; Aboutabl ME; El-Kadi AO
    Drug Metab Dispos; 2008 Nov; 36(11):2277-86. PubMed ID: 18725507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.